Results

Sellas Life Sciences Group Inc.

05/26/2022 | Press release | Archived content

Featured video - SELLAS Reports Preliminary Data Showing Clinical Benefit from Phase 1/2 Clinical Trial of Galinpepimut-S (GPS) in Combination with Keytruda® in Patients with[...]